OLMESARTAN MEDOXOMIL AMLOPIDINE BESYLATE Uses Warning Side effects Precautions Overdose & Brands-Watsons Health
Watsons Health

OLMESARTAN MEDOXOMIL AMLOPIDINE BESYLATE

Amlodipine is a calcium channel blocker. It works by bringing relaxation to the muscles of the heart and the blood vessels.

Olmesartan is an angiotensin II receptor antagonist. Olmesartan keeps blood vessels from narrowing, which brings down blood pressure and enhances blood flow.

Olmesartan Medoxomil Amlopidine Besylate is used in the following:

Do not give Olmesartan Medoxomil Amlopidine Besylate to people with the following conditions:

Olmesartan Medoxomil Amlopidine Besylate may have the following side effects:

  • Dizziness
  • Drowsiness
  • Swelling
  • Skin rash or itching
  • Flushing (warmth, redness, or tingly feeling)
  • Increased urination (especially at night)

Precautions

Take extra caution in patients with the following medical conditions:

  • Severe aortic stenosis and obstructive heart disease
  • Congestive heart failure
  • Impaired renal andhepatic function
  • Pregnancy andlactation
  • Elderly

 

Interactions

Olmesartan Medoxomil Amlopidine Besylate may interact with the following medicines:

  • Cyclosporine
  • Lithium
  • Simvastatin
  • Tacrolimus
  • NSAIDS(nonsteroidal anti-inflammatory drugs)
  • Aspirin
  • Ibuprofen
  • Meloxicam

If you think you may have used Olmesartan Medoxomil Amlopidine Besylate more than the usual dose, seek medical help immediately.

Available Brands:

  • Alzor CCB
  • Normetec
  • Olmezar-A
  • Tri-Alzor

 

Related Articles

TEMOPORFIN

Temoporfin is a porphyrin derivative that is used as a photosensitizing agent in photodynamic therapy. The antitumor activity of temoporfin is [...]

REVAPRAZAN

Revaprazan is a proton pump inhibitor which reversibly inhibits H+, K+-ATPase and is currently an investigational drug for the management of [...]

PAZOPANIB

Pazopanib is a synthetic second-generation tyrosine kinase (RTKs) inhibitor, which is involved in the initiation of signal transduction pathways that facilitates [...]